{"pub": "investing.com", "url": "https://au.investing.com/news/stock-market-news/boston-scientific-earnings-revenue-beat-in-q3-1977360", "downloaded_at": "2019-10-23 10:59:08.608896+00:00", "title": "Boston Scientific Earnings, Revenue beat in Q3", "language": "en", "text": "\u00a9 Reuters. Boston Scientific Earnings, Revenue beat in Q3\n\nInvesting.com - Boston Scientific (NYSE: ) reported third quarter that beat analysts' expectations on Wednesday and revenue that topped forecasts.\n\nThe firm reported earnings per share of $0.39 on revenue of $2.71B. Analysts polled by Investing.com forecast EPS of $0.38 on revenue of $2.65B. That compared to EPS of $0.35 on revenue of $2.39B in the same period a year earlier. The company had reported EPS of $0.39 on revenue of $2.63B in the previous quarter.\n\nFor the year, Boston Scientific shares are up 5.21%, under-performing the S&P Global (NYSE: ) 100 which is up 17.17% year to date.\n\nBoston Scientific follows other major Healthcare sector earnings this month\n\nOn Tuesday, October 15, 2019, J&J reported third quarter EPS of $2.12 on revenue of $20.73B, compared to forecasts of EPS of $2.01 on revenue of $20.08B.\n\nNovartis ADR earnings beat analyst's expectations on Tuesday, with third quarter EPS of $1.41 on revenue of $12.17B. Investing.com analysts expected EPS of $1.33 on revenue of $11.71B\n\nStay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar", "description": "Boston Scientific Earnings, Revenue beat in Q3", "authors": [], "top_image": "https://i-invdn-com.akamaized.net/news/LYNXMPEB280W7_L.jpg", "published_at": "2019-10-23"}